MedPath

Evaluation of the effectiveness of hypnotherapy on polycystic ovary syndrome

Phase 3
Conditions
polycystic ovarian syndrome.
Polycystic ovarian syndrome
E28.2
Registration Number
IRCT20161126031117N12
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
56
Inclusion Criteria

single or married women
with confirmed polycystic ovarian syndrome according to Rotterdam criteria
Have come to visit for the first time because of this disease
being able to read and write or speak in Persian
have Iranian nationality
being satisfied to participate in the research

Exclusion Criteria

Occurrence of any kind of acute complication affecting the quality of life and resilience during the intervention, such as the death of important people in a person's life.
being suffering from other endocrine diseases or any other chronic diseases which affect patient`s quality of life such as Chronic debilitating liver and kidney disease
being psychotic and having serious thoughts of harm to oneself and others (recognized by a psychiatrist)
being Infertile and undergoing assisted reproductive therapy
history of seizures
using psychotropic drugs and any kind of drug abuse
participating in similar training sessions

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath